CC
Cryo-Cell International, Inc.
CCEL · AMEX
$4.44 +0.57% (+$0.03)
1M +18.92%
Market Cap $35.8M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$6
35.1% upside
Current Price
$4.44
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CCEL is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
58 /100
Fair EV/EBITDA 76.51x
P/S 1.15x
P/FCF 5.86x
Growth
27 /100
Declining Rev. growth 1.33%
EPS growth N/A
FCF growth N/A
Profitability
50 /100
Moderate Gross margin 77.34%
Net margin 7.92%
Op. margin 0.33%
Quality
9 /100
Poor ROIC 0.22%
ROA 4.06%
Asset turnover 0.51x
Debt
4 /100
High Current ratio 0.71x
Int. coverage -0.32x
Net debt/EBITDA 14.61x
Stability
53 /100
Moderate Beta 0.55x
Rev. volatility 2.39%
EPS volatility 411.13%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CCEL
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
David Portnoy
Employees
74
Headquarters
Oldsmar
Upcoming events
09 OCT
Earnings
Upcoming earnings report